Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Waldbaum · SciRah

Researcher profile · Semantic Scholar

A. Waldbaum

Share profile

A. Waldbaum — researcher profile on SciRah

h-index: 15
Works: 24
Citations: 1,684

Most-cited papers

Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
J. Simon, G. Braunstein, L. Nachtigall, W. Utian +9 more
2005Journal of Clinical Endocrinology and Metabolism471 citations Open access
Semantic Scholar
Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial.
Marie-Claude Audet, M. Moreau, W. Koltun, A. Waldbaum +3 more
2001Journal of the American Medical Association (JAMA)332 citations
Semantic Scholar
Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study
J. Shifren, S. Davis, M. Moreau, A. Waldbaum +11 more
2006Menopause320 citations
Semantic Scholar
A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause
G. Fraser, S. Lederman, A. Waldbaum, R. Kroll +4 more
2020Menopause98 citations Open access
Semantic Scholar
Low Dose of Transdermal Estradiol Gel for Treatment of Symptomatic Postmenopausal Women: A Randomized Controlled Trial
J. Simon, C. Bouchard, A. Waldbaum, W. Utian +2 more
2007Obstetrics and Gynecology69 citations
Semantic Scholar
Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA)
N. Santoro, A. Waldbaum, S. Lederman, R. Kroll +5 more
2020Menopause62 citations Open access
Semantic Scholar
Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study.
F. Labrie, D. Archer, C. Bouchard, G. Girard +15 more
2015Maturitas59 citations
Semantic Scholar
Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial
D. Archer, S. Goldstein, J. Simon, A. Waldbaum +6 more
2019Menopause57 citations Open access
Semantic Scholar
Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy
Céline Bouchard, F. Labrie, D. Archer, D. Portman +12 more
2015Climacteric42 citations
Semantic Scholar
Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial.
S. Hillier, P. Nyirjesy, A. Waldbaum, J. Schwebke +3 more
2017Obstetrics and Gynecology28 citations
Semantic Scholar
Long-Term Evaluation of Safety and Health-Related Quality of Life in Women with Heavy Menstrual Bleeding Treated with Oral Tranexamic Acid
K. Muse, A. Lukes, J. Gersten, A. Waldbaum +2 more
2011Women's Health28 citations Open access
Semantic Scholar
Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
S. Chavoustie, B. Carter, A. Waldbaum, G. Donders +7 more
2019European Journal of Obstetrics, Gynecology, and Reproductive Biology27 citations Open access
Semantic Scholar
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
J. Schwebke, B. Carter, A. Waldbaum, K. Agnew +5 more
2020medRxiv26 citations Open access
Semantic Scholar
A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis
A. Waldbaum, J. Schwebke, J. Paull, C. Price +4 more
2020PLoS ONE21 citations Open access
Semantic Scholar
Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis: A Dose-Ranging Study
Steven Chavoustie, M. Jacobs, H. Reisman, A. Waldbaum +3 more
2015Journal of Lower Genital Tract Disease20 citations Open access
Semantic Scholar
Tranexamic Acid Increases Hemoglobin and Ferritin Levels in Women with Heavy Menstrual Bleeding
K. Muse, R. Garn Mabey, A. Waldbaum, J. Gersten +1 more
2012Journal of Women's Health11 citations
Semantic Scholar
The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: a randomized, placebo-controlled, double-blind, dose-ranging study
G. Fraser, S. Lederman, A. Waldbaum, Misun Lee +2 more
2019Maturitas4 citations
Semantic Scholar
6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis
Sharon L. Hillier, Franklin G. Morgan, A. Waldbaum, J. Schwebke +3 more
20154 citations
Semantic Scholar
OR33-6 The Neurokinin 3 Receptor Antagonist, Fezolinetant, Is Effective in Treatment of Menopausal Vasomotor Symptoms: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study
G. Fraser, S. Lederman, A. Waldbaum, Misun Lee +2 more
2019Journal of the Endocrine Society3 citations Open access
Semantic Scholar
Hormone Therapy : What Are We Doing in 2019 ?
N. Santoro, A. Waldbaum, S. Lederman, G. Fraser +15 more
20192 citations
Semantic Scholar
Acceptability of NuvaRing®, a new method of combined contraception
A. Waldbaum, S. Funk, N. Alexander
20022 citations Open access
Semantic Scholar
Long-term quality of life and safety of a new tranexamic acid menorrhagia treatment
K. Muse, J. Gersten, A. Waldbaum, R. Mabey +2 more
20101 citations Open access
Semantic Scholar
Novel, oral tranexamic acid improves the general quality of life (SF-36v2™ health survey measures) in women with menorrhagia
K. Muse, J. Gersten, A. Waldbaum, R. Mabey +2 more
20101 citations Open access
Semantic Scholar
The neurokinin 3 receptor antagonist, fezolinetant, is effective in treatment of menopausal vasomotor symptoms: responder analysis results from a randomized, placebo-controlled, double-blind, dose-ranging study
G. Fraser, S. Lederman, A. Waldbaum, James Young +2 more
2019Endocrine Abstracts0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Fraser×6
Invite
G. Fraser — researcher profile on SciRah
S. Lederman×6
Invite
S. Lederman — researcher profile on SciRah
L. Skillern×6
Invite
L. Skillern — researcher profile on SciRah
S. Ramael×6
Invite
S. Ramael — researcher profile on SciRah

×5

Invite

J. Schwebke — researcher profile on SciRah

Invite

C. Bouchard — researcher profile on SciRah

Invite

K. Muse — researcher profile on SciRah

Invite

J. Gersten — researcher profile on SciRah

Invite

J. Simon — researcher profile on SciRah

Invite

W. Koltun — researcher profile on SciRah

Invite

R. Kroll — researcher profile on SciRah

Invite

N. Santoro — researcher profile on SciRah